Synthesized mammography (SM) alone or with tomosynthesis may eliminate the need for full-field digital mammography (FFDM) in a routine clinical study, according to a study published online Jan. 21 by Radiology.

Identifying people who have elevated levels of dichlorodiphenyldichloroethylene (DDE), the byproduct of the pesticide dichlorodiphenyltrichloroethane (DDT), and carry an apolipoprotein ε4 (APOε4) allele may lead to early identification of some cases of Alzheimer disease (AD), according to a study published online by JAMA Neurology on Jan. 27.

Strategies to manage utilization in a fast-paced environment.

The industry for medical sensors, which includes diagnostic imaging and disease monitoring, was valued at $10.1 billion in 2012 and is expected to grow significantly by 2019, according to an industry sector report published Dec. 5 by Transparency Market Research.

A sweep of more than 550 articles from the medical literature on Alzheimer’s disease diagnosis left reviewers questioning the utility of a positive beta-amyloid scan, according to a meta-analysis published in the January issue of JAMA Internal Medicine. 

Antimicrobial peptide PET/CT imaging with gallium-68 appears to break through previous roadblocks in differentiating infections and sterile inflammatory processes, according to a study published Jan. 16 in the Journal of Nuclear Medicine.

A tiny molecular imaging system could be used on the field to measure brain injury or in the lab to capture individual molecules that betray the biology of cancer, neurodegenerative diseases such as Alzheimer's and viruses like human immunodeficiency virus (HIV). 

Siemens Healthcare has announced that the Food and Drug Administration (FDA) has cleared the RT Pro edition – a package of features designed to enhance radiation oncology workflow for Siemens’ SOMATOM Definition AS Open CT simulator.